194 related articles for article (PubMed ID: 2252104)
1. An immunohistochemical study of thymic epithelial tumors. III. The distribution of interdigitating reticulum cells and S-100 beta-positive small lymphocytes.
Kondo K; Mukai K; Sato Y; Matsuno Y; Shimosato Y; Monden Y
Am J Surg Pathol; 1990 Dec; 14(12):1139-47. PubMed ID: 2252104
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis, bcl-2 protein, and Fas antigen in thymic epithelial tumors.
Tateyama H; Eimoto T; Tada T; Inagaki H; Hattori H; Takino H
Mod Pathol; 1997 Oct; 10(10):983-91. PubMed ID: 9346177
[TBL] [Abstract][Full Text] [Related]
3. Thymic interdigitating cells express thioredoxin (TRX/ADF): an immunohistochemical study of 82 thymus and thymoma samples.
Go T; Isowa N; Hirata T; Yodoi J; Hitomi S; Wada H
Thymus; 1997; 24(3):157-71. PubMed ID: 9151381
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma.
Dorfman DM; Shahsafaei A; Miyauchi A
Mod Pathol; 1998 Oct; 11(10):989-94. PubMed ID: 9796728
[TBL] [Abstract][Full Text] [Related]
5. Expression of proteasome subunit β5t in thymic epithelial tumors.
Yamada Y; Tomaru U; Ishizu A; Kiuchi T; Marukawa K; Matsuno Y; Kasahara M
Am J Surg Pathol; 2011 Sep; 35(9):1296-304. PubMed ID: 21836487
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical and in situ hybridization detection of growth-hormone-producing cells in human thymoma.
Lauriola L; Maggiano N; Serra FG; Nori S; Tardio ML; Capelli A; Piantelli M; Ranelletti FO
Am J Pathol; 1997 Jul; 151(1):55-61. PubMed ID: 9212731
[TBL] [Abstract][Full Text] [Related]
7. B-cells in thymic epithelial tumours. An immunohistochemical analysis of intra- and extraepithelial B-cell compartments.
Fend F; Kirchner T; Marx A; Müller-Hermelink HK
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 63(4):241-7. PubMed ID: 7685134
[TBL] [Abstract][Full Text] [Related]
8. Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors.
Suzuki E; Sasaki H; Kawano O; Endo K; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
Jpn J Clin Oncol; 2006 Jun; 36(6):351-6. PubMed ID: 16762968
[TBL] [Abstract][Full Text] [Related]
9. The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors.
Chan JK; Tsang WY; Seneviratne S; Pau MY
Am J Surg Pathol; 1995 Oct; 19(10):1115-23. PubMed ID: 7573670
[TBL] [Abstract][Full Text] [Related]
10. [Morphometrical and immunohistochemical analysis of cortical and medullary thymoma: its correlation with invasiveness and association with myasthenia gravis].
Nomori H; Ishihara T; Torikata C
Nihon Kyobu Geka Gakkai Zasshi; 1990 Jan; 38(1):93-100. PubMed ID: 1691772
[TBL] [Abstract][Full Text] [Related]
11. CD5 expression in thymic carcinoma.
Hishima T; Fukayama M; Fujisawa M; Hayashi Y; Arai K; Funata N; Koike M
Am J Pathol; 1994 Aug; 145(2):268-75. PubMed ID: 7519823
[TBL] [Abstract][Full Text] [Related]
12. Proliferative activity and apoptosis in thymic epithelial neoplasms.
Hiroshima K; Iyoda A; Toyozaki T; Supriatna Y; Shibuya K; Shimamura F; Haga Y; Yoshida S; Fujisawa T; Ohwada H
Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014
[TBL] [Abstract][Full Text] [Related]
13. L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
J Surg Oncol; 2009 Jun; 99(7):433-8. PubMed ID: 19347882
[TBL] [Abstract][Full Text] [Related]
14. PE-35-related antigen expression and CD1a-positive lymphocytes in thymoma subtypes based on Müller-Hermelink classification. An immunohistochemical study using catalyzed signal amplification.
Hattori H; Tateyama H; Tada T; Saito Y; Yamakawa Y; Eimoto T
Virchows Arch; 2000 Jan; 436(1):20-7. PubMed ID: 10664158
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of 22 cases of thymoma.
Lee D; Wright DH
J Clin Pathol; 1988 Dec; 41(12):1297-304. PubMed ID: 2465318
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric study of lymphocytes associated with thymoma and other thymic tumors.
Fujii Y; Okumura M; Yamamoto S
J Surg Res; 1999 Apr; 82(2):312-8. PubMed ID: 10090845
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 is correlated with poor prognostic variables in patients with thymic epithelial tumors.
Sogawa K; Kondo K; Fujino H; Takahashi Y; Miyoshi T; Sakiyama S; Mukai K; Monden Y
Cancer; 2003 Nov; 98(9):1822-9. PubMed ID: 14584061
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells.
Kraus VB; Harden EA; Wittels B; Moore JO; Haynes BF
Am J Pathol; 1988 Sep; 132(3):552-62. PubMed ID: 3261946
[TBL] [Abstract][Full Text] [Related]
19. Degree of malignancy of thymic epithelial tumors in terms of nuclear DNA content and nuclear area. An analysis of 39 cases.
Asamura H; Nakajima T; Mukai K; Noguchi M; Shimosato Y
Am J Pathol; 1988 Dec; 133(3):615-22. PubMed ID: 3202120
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma.
Hishima T; Fukayama M; Hayashi Y; Fujii T; Arai K; Shiozawa Y; Funata N; Koike M
Hum Pathol; 1998 Apr; 29(4):330-8. PubMed ID: 9563781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
